With the constant deepening of research, the role of the mTOR signaling pathway in the pathogenesis of CSCC has been gradually clarified and anticancer drugs targeting the mTOR signaling pathway may become new targeted drugs for CSCC. This evidence concerns the gene MTOR and skin squamous cell carcinoma.